Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Mononuclear phagocytes - origins, fates and functions
- Prof. Steffen Jung
-
2. Transcription factors in macrophage differentiation
- Dr. Michael Sieweke
-
3. Fetal macrophages
- Prof. Paul Martin
-
4. The alveolar macrophage
- Dr. Ronald G. Crystal
-
5. Airway macrophages in health and disease
- Prof. Tracy Hussell
-
6. Intestinal macrophages - heterogeneity, origins and functions
- Prof. Allan Mowat
-
7. Osteoclasts: what do they do and how do they do it?
- Prof. Steven L. Teitelbaum
-
8. The biology of Fc receptors and complement receptors
- Prof. Steven Greenberg
-
10. Tumour-associated macrophages
- Prof. Michele De Palma
- Dr. Mario Squadrito
-
11. The recognition of pathogens by C-type lectins
- Prof. Gordon D. Brown
-
12. Macrophage phagocytosis
- Prof. Joel Swanson
-
13. Macrophage CD36 and atherosclerosis
- Dr. Maria Febbraio
-
14. Toll-Like receptor signaling and the innate immune response
- Dr. Kate Fitzgerald
-
15. Innate immune receptors as mediators of systemic inflammation and pathogenesis of malaria
- Prof. Ricardo Gazzinelli
-
17. Triggering receptors expressed on myeloid cells (TREM)
- Dr. Daniel W. McVicar
-
18. Influence of eicosanoid lipid mediators on macrophage innate immune functions
- Prof. Marc Peters-Golden
-
19. Macrophage paired receptor interactions
- Prof. Neil Barclay
-
20. Macrophage heterogeneity in atherosclerosis regression
- Prof. Edward Fisher
-
21. Gaucher disease: from lysosomal storage to immunopathology
- Prof. Johannes M.F.G. Aerts
-
22. Macrophage in asthma
- Prof. Douglas Robinson
-
23. The macrophage mannose receptor
- Dr. Luisa Martinez-Pomares
-
24. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
25. EGF-TM7 receptors
- Dr. Jörg Hamann
- Dr. Hsi-Hsien Lin
-
26. Macrophages in helminth infection
- Prof. Judith Allen
- Archived Lectures *These may not cover the latest advances in the field
-
27. Immunosuppressive mechanisms in myeloid cells
- Prof. Dmitry Gabrilovich
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture outline
- Macrophages - general attributes
- Macrophages and receptor recognition
- CD36 structure
- CD36: regions within the protein
- CD36: function and membrane distribution
- CD36: a multifunctional membrane glycoprotein (1)
- CD36: a multifunctional membrane glycoprotein (2)
- Atherogenesis and monocytes/macrophages
- A tale of two mice
- Experimental design of atherosclerosis in mice
- The aortic tree in mice and humans
- Absence of CD36 & atherosclerosis in apoEo mice
- ApoEo vs. ApoEo/CD36o: degree of lesions
- Lesions in LDLRo mice are not CD36 dependent
- LDLRo vs. LDLRo/CD36o lesion burden
- Foam cell formation in LDLRo is CD36 dependent
- CD36 may not be the atherogenic ligand in LDLRo
- In vivo foam cell assay
- The ligand in the 2 mouse models differs
- Ligand may differ in a CD36 dependent manner
- Making the LDL in the LDLRo a ligand for CD36
- LDLRo vs. CD36o/LDLRo + high cholesterol diet
- LDLR KO's: hyperlipidemia and inflammation
- Inflammation, CD36 ligands and atherosclerosis
- CD36 specific ligands in oxidatively modified LDL
- CD36 ligands are choline glycerophospholipids
- How CD36 detects differences in phospholipids
- Multiple pathways may create CD36R ligands
- Recognition of altered self ligands by CD36
- Summary
- Acknowledgements
Topics Covered
- Scavenger receptors
- Structure of CD36
- Role of CD36
- The link between inflammation and CD36
- Risk factors for inflammation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Febbraio, M. (2013, January 30). Macrophage CD36 and atherosclerosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/LVLM9718.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Maria Febbraio has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.